TrialCNS neuroscience & therapeutics2025
Phase 2 Trial of PD-1 Inhibitor Sintilimab in Recurrent/Progressive Meningioma.
Yali Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papertrialcites it
TrialCNS neuroscience & therapeutics2025
Yali Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.